|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Pandion Therapeutics, Inc. (PAND) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
28,530,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shah Rajeev M. |
10% Owner |
– – • |
2020-07-21 |
4 |
B |
$18.00 |
$6,499,998 |
I/I |
361,111 |
1,770,023 |
1.5 |
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
1,408,912 |
1,408,912 |
|
- |
|
| Glaxosmithkline Plc |
Director |
– • • |
2020-07-21 |
4 |
B |
$18.00 |
$6,499,998 |
I/I |
361,111 |
2,248,304 |
2.25 |
- |
|
| Glaxosmithkline Plc |
Director |
– • • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
1,887,193 |
1,887,193 |
|
- |
|
| Goyal Vikas |
See Remarks |
• – – |
2020-07-21 |
4 |
B |
$18.00 |
$26,100 |
D/D |
1,450 |
87,764 |
2.74 |
- |
|
| Goyal Vikas |
See Remarks |
• – – |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
7,044 |
86,314 |
|
- |
|
| Versant Vantage I Gp-Gp, Llc |
10% Owner |
– – • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
577,544 |
577,544 |
|
- |
|
| Versant Vantage I Gp-Gp, Llc |
10% Owner |
– – • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
3,176,507 |
3,176,507 |
|
- |
|
| Sundy John |
Chief Medical Officer |
• – – |
2020-07-21 |
4 |
B |
$18.00 |
$36,000 |
D/D |
2,000 |
115,826 |
2.74 |
- |
|
| Frail Donald |
Director |
– • – |
2020-07-21 |
4 |
B |
$18.00 |
$180,000 |
D/D |
10,000 |
61,113 |
2.39 |
- |
|
| Frail Donald |
Director |
– • – |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
11,741 |
51,113 |
|
- |
|
| Mva Investors, Llc |
10% Owner |
– – • |
2020-07-21 |
4 |
B |
$18.00 |
$12,999,996 |
D/D |
722,222 |
2,107,513 |
2.45 |
- |
|
| Mva Investors, Llc |
10% Owner |
– – • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
23,622 |
23,622 |
|
- |
|
| Mva Investors, Llc |
10% Owner |
– – • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,385,291 |
1,385,291 |
|
- |
|
| Polaris Partners Viii, L.p. |
10% Owner |
– – • |
2020-07-21 |
4 |
B |
$18.00 |
$649,998 |
I/I |
36,111 |
110,621 |
1.5 |
- |
|
| Polaris Partners Viii, L.p. |
10% Owner |
– – • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
3,165,311 |
109,373 |
|
- |
|
| Fuglesang Christopher |
Director |
– • • |
2020-07-21 |
4 |
B |
$18.00 |
$12,999,996 |
I/I |
722,222 |
2,600,773 |
2.25 |
- |
|
| Fuglesang Christopher |
Director |
– • • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
1,408,913 |
1,408,913 |
|
- |
|
| Carroll Jill |
Director |
– • • |
2020-07-21 |
4 |
B |
$18.00 |
$6,499,998 |
I/I |
361,111 |
2,248,304 |
2.25 |
- |
|
| Carroll Jill |
Director |
– • • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
1,887,193 |
1,887,193 |
|
- |
|
| Stagliano Nancy |
Director |
– • – |
2020-07-21 |
4 |
B |
$18.00 |
$18,000 |
D/D |
1,000 |
1,000 |
2.39 |
- |
|
| Stagliano Nancy |
Director |
– • – |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
15,004 |
73,067 |
|
- |
|
| Jdrf T1d Fund Llc |
10% Owner |
– – • |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
D/D |
426,333 |
426,333 |
|
- |
|
| Kakkar Rahul |
Chief Executive Officer |
• • – |
2020-07-21 |
4 |
B |
$18.00 |
$252,000 |
D/D |
14,000 |
14,000 |
2.81 |
- |
|
| Kakkar Rahul |
Chief Executive Officer |
• • – |
2020-07-21 |
4 |
A |
$0.00 |
$0 |
I/I |
21,133 |
702,515 |
|
- |
|
72 Records found
|
|
Page 2 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
